Aeronid200 HFA

Indications

Aeronid inhaler is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and paediatric patients six years of age or older. It is also indicated for patients requiring oral corticosteroid therapy for asthma, many of those patients may be able to reduce or eliminate their requirement for oral corticosteroids over time. Aeronid inhaler is not indicated for the relief of acute bronchospasm.

Pharmacology

Budesonide inhaler is a corticosteroid that exhibits potent glucocorticoid activity and weak mineralocorticoid activity. Corticosteroids have been shown to have a wide range of inhibitory activities against multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g., histamine, eicosanoids, leukotrienes, and cytokines) involved in allergic and non-allergic inflammation.

Dosage & Administration

Adult (Bronchodilators alone): Recommended starting dose 200 to 400 mcg twice daily; Highest recommended dose 400 mcg twice daily. Adult (Inhaled corticosteroids): Recommended starting dose 200 to 400 mcg twice daily; Highest recommended dose 800 mcg twice daily. Children (Bronchodilators alone): Recommended starting dose 200 mcg twice daily; Highest recommended dose 400 mcg twice daily.

Side Effects

Headache, flu-like syndrome, pain, back pain, fever. Respiratory: respiratory tract infections, pharyngitis, sinusitis, rhinitis, voice alteration, cough aggravation. Digestive: oral candidiasis, dyspepsia, gastroenteritis, nausea, abdominal pain. Musculoskeletal: fracture, myalgia, arthralgia. Nervous system: syncope, hypertonia, migraine.

Precautions & Warnings

During withdrawal from oral corticosteroids, some patients may experience symptoms of systemically active corticosteroid withdrawal, e.g., joint and/or muscular pain, lassitude, and depression, despite maintenance or even improvement of respiratory function. Since Aeronid is absorbed into the circulation and can be systemically active at higher doses, the full beneficial effects in minimising HPA dysfunction may be expected only when recommended dosages are not exceeded.

Contraindications

Budesonide inhalation aerosol is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. Hypersensitivity to Budesonide contraindicates the use of Budesonide inhaler.

Pregnancy & Lactation

No specific information available in this source. Consult your physician before use during pregnancy or lactation.

Storage Conditions

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting any medication.